Searched for
ARROW PHARMACEUTICALS
Stock market update: Nifty Pharma index advances 0.42% in an upbeat marketThe Nifty Pharma index was trading 0.42 per cent up at 11923.25.- Stock market update: Nifty Pharma index advances 0.29% in a weak marketThe Nifty Pharma index was trading 0.29 per cent up at 11788.5.
- Stock market update: Nifty Pharma index advances 1.04%The Nifty Pharma index closed 1.04 per cent up at 11754.7.
- Stock market update: Nifty Pharma index falls 0.14%The Nifty Pharma index closed 0.14 per cent down at 11683.95.
- Stock market update: Nifty Pharma index advances 0.13% in an upbeat marketThe Nifty Pharma index was trading 0.13 per cent up at 13104.5.
- Stock market update: Nifty Pharma index advances 0.78%The Nifty Pharma index closed 0.78 per cent up at 12721.0.
- Natco Pharma announces launch of first generic of top selling cancer drug RevlimidRevlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available i...
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...
- Batches of Strides' Ranitidine tablets now available for sale in AustraliaOut of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have an NDMA level at or above the acceptable limi...
- Strides Pharma arm signs pacts for sale of Australian business to Arrow PharmaThe company said it expects the transaction to close on or around July 10, 2019.
- Strides to exit investment in Arrow for AUD 394 millionIn a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent ...
- Australian Competition and Consumer Commission clears Arrow and Apotex merger: StridesIn May 2018, Strides Pharma Science Ltd announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company.
- Top stocks in focus on Friday, 1 September 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Arrow Pharma acquires Australian operations of Amneal PharmaUnder the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...
- Shares of Arrow GreenTech surge on FootNoteThe company's website says it holds patents in high-strength paper and its manufacturing process, some of whose features are similar to tho...
- Strides Shasun plans to divest British subsidiary for Rs 240 croreThe supply agreement is an extension to the existing supply arrangement previously in place between Pharmacy Alliance and Aspen.
- Strides Arcolab Q2 net profit rises to Rs 19 croreConsolidated total income of the company rose to Rs 370 crore for the quarter under review. It was Rs 286.97 crore for the same period year...
- Strides Arcolab completes acquisition of Aspen's generic business in AustraliaThe acquisition included access to the product pipeline that was under development by Aspen and a number of major product launches slated f...
- Strides Arcolab to get product pipeline developed by AspenStrides Arcolab has said its deal with Aspen Pharmacare to buy the latter's Australia assets will help the Indian drug company rebuild its ...
- Strides Arcolab surges as company to buy some Australia drug assets from South Africa's Aspen Pharmacare; ends 8% higherStrides Arcolab today said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for ab...
Load More
